Niki BioSolutions, Inc. - Common Stock (NIKI)

5.2600
+0.4900 (10.27%)
NASDAQ · Last Trade: Sep 17th, 4:29 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close4.770
Open4.850
Bid2.000
Ask5.290
Day's Range4.780 - 5.290
52 Week Range4.648 - 12.24
Volume137,417
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume235,319

Chart

News & Press Releases

Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics
Advanced multi-omics data analysis and biostatistical expertise to sharpen target and biomarker decisions across the platform
By Niki BioSolutions, Inc. · Via GlobeNewswire · September 14, 2026
Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Live company presentation will take place on September 14 at 10:30 AM ET
By Niki BioSolutions, Inc. · Via GlobeNewswire · September 8, 2026
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology (NASDAQ:ZYBT) shares
Via Benzinga · July 23, 2026
Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)
Partnership Expands Access to Clinically Critical Genetic Testing in Support of Leading Research Programs
By Niki BioSolutions, Inc. · Via GlobeNewswire · July 23, 2026